Polymorphism of the androgen receptor gene is associated with male pattern baldness
- PMID: 11231320
- DOI: 10.1046/j.1523-1747.2001.01261.x
Polymorphism of the androgen receptor gene is associated with male pattern baldness
Abstract
The common heritable loss of scalp hair known as male pattern baldness or androgenetic alopecia affects up to 80% of males by age 80. A balding scalp is characterized by high levels of the potent androgen dihydrotestosterone and increased expression of the androgen receptor gene. To determine if the androgen receptor gene is associated with male pattern baldness, we compared allele frequencies of the androgen receptor gene polymorphisms (StuI restriction fragment length polymorphism and two triplet repeat polymorphisms) in cases with cosmetically significant baldness (54 young and 392 older men) and controls (107 older men) with no indication of baldness. The androgen receptor gene StuI restriction site was found in all but one (98.1%) of the 54 young bald men (p = 0.0005) and in 92.3% of older balding men (p = 0.000004) but in only 76.6% of nonbald men. The combination of shorter CAG and GGC triplet repeat lengths was also more prevalent in bald men (p = 0.03). The ubiquity of the androgen receptor gene StuI restriction site, and higher incidence of shorter triplet repeat haplotypes in bald men suggests that these markers are very close to a functional variant that is a necessary component of the polygenic determination of male pattern baldness. Functional mutation in or near the androgen receptor gene may explain the reported high levels of expression of this gene in the balding scalp.
Similar articles
-
The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia.Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):993-6. doi: 10.1158/1055-9965.EPI-04-0778. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15824176
-
Insulin gene polymorphism and premature male pattern baldness in the general population.Clin Sci (Lond). 1999 Jun;96(6):659-62. Clin Sci (Lond). 1999. PMID: 10334972
-
Genetic analysis of male pattern baldness and the 5alpha-reductase genes.J Invest Dermatol. 1998 Jun;110(6):849-53. doi: 10.1046/j.1523-1747.1998.00224.x. J Invest Dermatol. 1998. PMID: 9620288
-
Androgen receptor gene polymorphisms and risk for androgenetic alopecia: a meta-analysis.Clin Exp Dermatol. 2012 Mar;37(2):104-11. doi: 10.1111/j.1365-2230.2011.04186.x. Epub 2011 Oct 10. Clin Exp Dermatol. 2012. PMID: 21981665 Review.
-
Male androgenetic alopecia.Expert Opin Pharmacother. 2010 Jun;11(8):1295-304. doi: 10.1517/14656561003752730. Expert Opin Pharmacother. 2010. PMID: 20426708 Review.
Cited by
-
[Androgenetic alopecia].Hautarzt. 2004 Jan;55(1):89-111; quiz 110-1. doi: 10.1007/s00105-003-0673-4. Hautarzt. 2004. PMID: 14997872 German.
-
Male-pattern hair loss: Comprehensive identification of the associated genes as a basis for understanding pathophysiology.Med Genet. 2023 Apr 5;35(1):3-14. doi: 10.1515/medgen-2023-2003. eCollection 2023 Apr. Med Genet. 2023. PMID: 38835416 Free PMC article.
-
Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy.Cells. 2021 Oct 30;10(11):2957. doi: 10.3390/cells10112957. Cells. 2021. PMID: 34831180 Free PMC article. Review.
-
Relationship between male pattern baldness and the risk of aggressive prostate cancer: an analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.J Clin Oncol. 2015 Feb 10;33(5):419-25. doi: 10.1200/JCO.2014.55.4279. Epub 2014 Sep 15. J Clin Oncol. 2015. PMID: 25225425 Free PMC article.
-
Relation of urinary stone disease with androgenetic alopecia and serum testosterone levels.Urolithiasis. 2016 Oct;44(5):409-13. doi: 10.1007/s00240-016-0888-3. Epub 2016 May 7. Urolithiasis. 2016. PMID: 27155830
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases